KRW 6560.0
(-4.51%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.05 Billion KRW | -71.05% |
2022 | 7.11 Billion KRW | 28.72% |
2021 | 5.52 Billion KRW | 897.77% |
2020 | 553.85 Million KRW | 18.92% |
2019 | 465.73 Million KRW | 0.0% |
2018 | - KRW | -100.0% |
2017 | 3 Billion KRW | 0.0% |
2016 | 3 Billion KRW | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 1.91 Billion KRW | -6.94% |
2024 Q2 | 1.82 Billion KRW | -4.52% |
2023 Q4 | 2.05 Billion KRW | -4.43% |
2023 FY | 2.05 Billion KRW | -71.05% |
2023 Q3 | 2.15 Billion KRW | -10.62% |
2023 Q2 | 2.41 Billion KRW | -14.03% |
2023 Q1 | 2.8 Billion KRW | -60.58% |
2022 Q2 | 6.41 Billion KRW | 11.12% |
2022 Q1 | 5.77 Billion KRW | 4.44% |
2022 Q3 | 6.74 Billion KRW | 5.2% |
2022 Q4 | 7.11 Billion KRW | 5.44% |
2021 Q4 | 5.52 Billion KRW | 3.85% |
2021 Q3 | 5.32 Billion KRW | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 697.79 Million KRW | -195.125% |
InBody Co.,Ltd | 6.08 Billion KRW | 66.13% |
Seegene, Inc. | 141.76 Billion KRW | 98.547% |
i-SENS, Inc. | 143.79 Billion KRW | 98.568% |
Ray Co., Ltd. | 86.67 Billion KRW | 97.624% |
Gencurix Inc. | 17.95 Billion KRW | 88.53% |
Sugentech Inc. | 15.3 Billion KRW | 86.543% |
L&C Bio Co., Ltd | 82.13 Billion KRW | 97.493% |